G·Life Awarded Deeptech Recognition for Its Innovative Research

G·Life has obtained Deeptech recognition by Bpi France, highlighting the scientific and technological ambition of its Quantum Biomodulation approach.

Its research strategy is structured around three complementary programs: understanding the interactions between light and biological tissues, investigating the effects of photobiomodulation on tissue development and regeneration, and exploring its mechanisms of action on different cell types under stress conditions.

Together, these programs aim to deepen the scientific understanding of light-based biological modulation and support the development of future medical applications.

The program relies on scientific and academic collaborations involving EPFL, LAPP/CNRS-IN2P3, Aix-Marseille University, University of Geneva (Switzerland), and the Geneva School of Landscape, Engineering and Architecture (HEPIA, Switzerland).

Janvier - 2025

Patent Granted for Innovative Photobiomodulation Device and Method

Our company is pleased to announce the grant of a new patent for our invention entitled "DEVICE AND METHOD FOR APPLYING PHOTOBIOMODULATION". This innovation relies on an advanced photobiomodulation (PBM) device and method capable of delivering optical power precisely tailored to the target biological optical properties and illumination geometry. By applying specifically calibrated fluence rates and exposure durations, our technology optimizes biological responses while enabling optional real-time metabolic activity monitoring. This major milestone strengthens our intellectual property portfolio and confirms our dedication to pioneering medical technologies.

Septembre - 2025